Search
Inhibikase Therapeutics Inc
IKTAdd to Watchlist
2.330USD
+0.160+7.37%
Close 07-23 16:00（ET）Quotes delayed by 15 min
307.64MMarket Cap
LossP/E TTM
IKT Financials
See Inhibikase Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Inhibikase Therapeutics Inc Earnings Date
Latest Release
May 12, 2026
EPS / Forecast
-0.10/-0.11
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-0.49
57.70%
Analyst Rating
BUY
2026/07/23
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What are the current assets of Inhibikase Therapeutics Inc?
According to Inhibikase Therapeutics Inc's FY2025 earnings report, its current assets were 180.11M, with a year-on-year change of 82.94.
What are the total assets of Inhibikase Therapeutics Inc?
According to Inhibikase Therapeutics Inc's FY2025 earnings report, its total assets of Inhibikase Therapeutics Inc were 181.20M, with a year-on-year change of 83.78.
What are the total liabilities of Inhibikase Therapeutics Inc?
According to Inhibikase Therapeutics Inc's FY2025 earnings report, its total liabilities of Inhibikase Therapeutics Inc were 8.30M, with a year-on-year change of 122.33.
What is the total equity of Inhibikase Therapeutics Inc?
According to Inhibikase Therapeutics Inc's FY2025 earnings report, its total equity of Inhibikase Therapeutics Inc was 172.90M, with a year-on-year change of 82.26.
What is the net operating income of Inhibikase Therapeutics Inc?
According to Inhibikase Therapeutics Inc's FY2025 earnings report, its net operating income of Inhibikase Therapeutics Inc was -45.95M, with a year-on-year change of -60.72.
What is the net investment of Inhibikase Therapeutics Inc?
According to Inhibikase Therapeutics Inc's FY2025 earnings report, its net investment of Inhibikase Therapeutics Inc was 2.05M, with a year-on-year change of 105.55.
What is the net financing of Inhibikase Therapeutics Inc?
According to Inhibikase Therapeutics Inc's FY2025 earnings report, its net financing of Inhibikase Therapeutics Inc was 108.46M, with a year-on-year change of 4.82.
What is the Earnings Per Share (EPS) of Inhibikase Therapeutics Inc?
According to Inhibikase Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.49, with a year-on-year change of 57.70.
What is the net income of Inhibikase Therapeutics Inc?
According to Inhibikase Therapeutics Inc's FY2025 earnings report, its net income was -48.26M, with a year-on-year change of -75.36.
What is the Return on Equity (ROE) of Inhibikase Therapeutics Inc?
According to Inhibikase Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -36.05, with a year-on-year change of 30.68.
What is the Return on Assets (ROA) of Inhibikase Therapeutics Inc?
According to Inhibikase Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -34.49, with a year-on-year change of 29.11.
What is the operating profit of Inhibikase Therapeutics Inc?
According to Inhibikase Therapeutics Inc's FY2025 earnings report, its operating profit was -45.95M, with a year-on-year change of -60.72.